Craig Venter, president and chairman of the Center for the Advancement of Genomics, has been awarded the EMC Information Leadership award.
Venter, who led genome sequencing efforts at Celera Genomics, was recognized for his innovative use of information technology in life sciences. Officials from EMC gave Venter the award at a ceremony last week.
EMC, a network storage giant, established the award two years ago to honor an individual or organization that exhibits “a sustained commitment to innovation through information.” Last year’s recipient was Edward Johnson 3d, chairman and CEO of Fidelity Investments.
Venter is currently also president and chairman of the Institute for Biological Energy Alternatives and the J. Craig Venter Science Foundation.
Robert Ellis has been named chief operating officer of BioTrove, of Woburn, Mass.
Ellis comes to BioTrove from Affymetrix, where he was executive vice president. He previously was president of microarray company Genometrix, and served in senior executive posts at Applied Biosystems, where he led marketing of the company’s first automated sequencer, and PerkinElmer.
BioTrove focuses on microfluidics and nanofluidics devices for drug discovery.
Anne Pilaro has been appointed senior director of regulatory affairs at Gene Logic subsidiary TherImmune Research.
TherImmune is a drug discovery, pre-clinical, and clinical trial contract research organization, which Gene Logic acquired in April for $52 million.
Pilaro comes to TherImmune from the FDA office of therapeutics research and review in the Center for Biologics Evaluation and Research (CBER). Her work at FDA involved gene therapy, as well as review of products in multiple sclerosis, hepatitis, and rheumatoid arthritis, Gene Logic said.
In the position, Pilaro will advise TherImmune clients on FDA regulatory policies and submissions.
Applied DNA Sciences has appointed security access expert John Camp as a strategic business consultant. Camp will help deploy the company’s Applied DNA Security Access System.
Camp comes to Applied DNA Sciences from Sanbar Corporation, where he was vice president of marketing and sales for five years.
Exelixis has appointed Steven James senior vice president of commercial operations. James will be responsible for “managing and expanding the company’s business-development and corporate-development activities,” and developing a strategy for pre-commercial and commercial operations. He will report directly to George Scangos, president and CEO.
James comes to Exelixis from Sunesis Pharmaceuticals, where he served most recently as chief business officer.